MedPath

Iron Deficiency Anemia Among Chinese Pregnant Women: a Multi-center Prospective Cohort Study

Completed
Conditions
Iron Deficiency Anemia of Pregnancy
Interventions
Other: Iron deficiency anemia in Chinese pregnant women
Registration Number
NCT03961074
Lead Sponsor
West China Hospital
Brief Summary

Iron deficiency anemia during pregnancy, which may lead to adverse pregnancy outcomes, was a serious health problem in China. Various iron supplements used in different regions of China, however, the effects have not been well investigated. The objective of this study is to investigate the diagnosis, treatment and prognosis of iron deficiency and iron deficiency anemia in Chinese pregnant women.

Detailed Description

This is a nationwide multicenter prospective cohort study conducted in seven hospitals in China to investigate the diagnosis, treatment and prognosis of iron deficiency and iron deficiency anemia in Chinese pregnant women. This study will enroll about 6000-7000 pregnant women, who established a health record in the seven hospitals. Demographic characteristics, laboratory tests, behavior habits during pregnancy, mental status, and pregnancy outcomes will been collected. All information will collect by a pregnant women self-reported questionnaire and the electronic medical record system in hospitals at three timing points: 6-15 gestational weeks, 30-34 gestational weeks and one week after delivery.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
5551
Inclusion Criteria
  • Pregnant women who registered an antenatal care file at the survey hospital ;
  • Signed informed consent.
Exclusion Criteria
  • Participated in any drug or nutritional clinical trial from 3 months before pregnancy to recruitment.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Exposure groupIron deficiency anemia in Chinese pregnant womenChinese women with iron deficiency anemia (IDA) during pregnancy.
Primary Outcome Measures
NameTimeMethod
adverse maternal outcomes40 weeks

Including iron deficiency anemia rate, pregnancy hypertension syndrome rate, gestational diabetes mellitus rate, cesarean section rate, and other adverse maternal outcomes rate. The definition of adverse maternal outcome was according to International Glossary on Infertility and Fertility Care (2017), and the rate of adverse maternal outcome was calculated by the number of adverse maternal outcome divided by the total number of pregnant women.

adverse neonatal outcomes40 weeks

Including miscarriage rate, premature birth rate, birth defect rate, low birth weight rate, and other adverse neonatal outcomes. The definitions of adverse neonatal outcomes were according to International Glossary on Infertility and Fertility Care (2017), and the rate of adverse neonatal outcomes were calculated by the number of advers neonatal outcomes divided by the total number of pregnancy or birth.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (7)

Peking University People's Hospital

🇨🇳

Beijing, Beijing, China

Chongqing Health center for women and Children

🇨🇳

Chongqing, Chongqing, China

Xiamen Maternal and Child Care Hospital

🇨🇳

Xiamen, Fujian, China

Yanan University Affiliated Hospital

🇨🇳

Yanan, Shanxi, China

Women'S Hospital School of Medicine Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

Hubei Maternal and Child Care Hospital

🇨🇳

Wuhan, Hubei, China

The West China Second University Hospital

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath